• Narrow screen resolution
  • Wide screen resolution
  • Auto width resolution
  • Decrease font size
  • Default font size
  • Increase font size
Innovation, Technology and Patent Policy
The issues are particularly complex when it comes to new technologies such as biotechnology, nanotechnology and technologies in the information and communications sector (ICTs). As patents become more important in determining access to fundamental research, essential products and services, and to economic development generally, it is critical that patent policy be subject to closer scrutiny by policy makers and researchers.

 

Title Filter     Display # 
# Article Title
1 Access to Medicines and Intellectual Property: The contribution of the World Health Organization
2 Trade and Investment Agreements—Barriers to National Public Health and Tobacco Control Measures
3 Rethinking The R&D Model for Pharmaceutical Products: A Binding Global Convention
4 Mechanisms for International Cooperation in Research and Development: Lessons for the Context of Climate Change
5 Rethinking Global Health: A Binding Convention for R&D for Pharmaceutical Products
6 The Doha Declaration on TRIPS and Public Health Ten Years Later: The State of Implementation
7 Pharmaceutical Innovation, Incremental Patenting and Compulsory Licensing
8 The Nagoya Protocol on Access and Benefit Sharing of Genetic Resources: Analysis and Implementation Options for Developing Countries
9 The Nagoya ABS Protocol and Pathogens
10 The Right to Health and Medicines: The Case of Recent Negotiations on the Global Strategy on Public Health, Innovation and Intellectual Property
11 Intellectual Property Enforcement - International Perspectives
12 Policy Space for Domestic Public Interest Measures Under TRIPS
13 IPR Misuse: The Core Issue in Standards and Patents
14 Patent Counts as Indicators of the Geography of Innovation Activities: Problem and Perspectives
15 South Perspective - A Guide to Pharmaceutical Patents (Volume 1 and 2)
16 The Use of Flexibilities in TRIPS by Developing Countries: Can they Promote Access to Medicines?
17 Utilizing TRIPS Flexibilities for Public Health Protection Through South-South Regional Frameworks
18 The WIPO Draft Substantive Patent Law Treaty: a Review of Selected Provisions
19 Protection and Promotion of Traditional Medicines: Implications for Public Health in Developing Countries
20 The WIPO Patent Agenda: the Risks for Developing Countries
21 The International Debate on Traditional Knowledge as Prior Art in the Patent System: Issues and Options for Developing Countries
22 Integrating Public Health Concerns into Patent Legislation in Developing Countries
23 Protection of Data Submitted for the Registration of Pharmaceuticals: Implementing the Standards of the TRIPS Agreement
24 Technical Issues on Protecting Plant Varieties by Effective Sui Generis Systems
25 Intellectual Property Rights and the Use of Compulsory Licenses: Options for Developing Countries